|
1
|
Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann
JV, Hruban RH, Goodman SN, Dooley WC, Coleman J and Pitt HA:
Pancreaticoduodenectomy for cancer of the head of the pancreas. 201
patients. Ann Surg. 221:721–731; discussion 731–733. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Busquets J, Fabregat J, Jorba R, Borobia
FG, Valls C, Serrano T, Torras J and Lladó L: Indications and
results of pancreatic surgery preserving the duodenopancreatic
region. Cir Esp. 82:105–111. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hong SM, Kelly D, Griffith M, Omura N, Li
A, Li CP, Hruban RH and Goggins M: Multiple genes are
hypermethylated in intraductal papillary mucinous neoplasms of the
pancreas. Mod Pathol. 21:1499–1507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Majumder S, Chari ST and Ahlquist DA:
Molecular detection of pancreatic neoplasia: Current status and
future promise. World J Gastroenterol. 21:11387–11395. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mu DQ, Peng YS and Xu QJ: Values of
mutations of K-ras oncogene at codon 12 in detection of pancreatic
cancer: 15-year experience. World J Gastroenterol. 10:471–475.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Corbo V, Tortora G and Scarpa A: Molecular
pathology of pancreatic cancer: From bench-to-bedside translation.
Curr Drug Targets. 13:744–752. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mora J, Urgell E, Farré A, Comas L,
Montserrat E and González-Sastre F: Agreement between K-ras
sequence variations detected in plasma and tissue DNA in pancreatic
and colorectal cancer. Clin Chem. 52:1448–1449. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Boadas J, Mora J, Urgell E, Puig P, Roca
M, Cussó X, Capellà G, Lluís F and Farré A: Clinical usefulness of
K-ras gene mutation detection and cytology in pancreatic juice in
the diagnosis and screening of pancreatic cancer. Eur J
Gastroenterol Hepatol. 13:1153–1159. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ha A, Watanabe H, Yamaguchi Y, Ohtsubo K,
Wang Y, Motoo Y, Okai T, Wakabayahi T and Sawabu N: Usefulness of
supernatant of pancreatic juice for genetic analysis of K-ras in
diagnosis of pancreatic carcinoma. Pancreas. 23:356–363. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Löhr M, Müller P, Mora J, Brinkmann B,
Ostwald C, Farré A, Lluis F, Adam U, Stubbe J, Plath F, et al: p53
and K-ras mutations in pancreatic juice samples from patients with
chronic pancreatitis. Gastrointest Endosc. 53:734–743. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Azuara D, Ginesta MM, Gausachs M,
Rodriguez-Moranta F, Fabregat J, Busquets J, Pelaez N, Boadas J,
Galter S, Moreno V, et al: Nanofluidic digital PCR for KRAS
mutation detection and quantification in gastrointestinal cancer.
Clin Chem. 58:1332–1341. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sato N, Fukushima N, Matsubayashi H,
Iacobuzio-Donahue CA, Yeo CJ and Goggins M: Aberrant methylation of
Reprimo correlates with genetic instability and predicts poor
prognosis in pancreatic ductal adenocarcinoma. Cancer. 107:251–257.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sakai M, Hibi K, Koshikawa K, Inoue S,
Takeda S, Kaneko T and Nakao A: Frequent promoter methylation and
gene silencing of CDH13 in pancreatic cancer. Cancer Sci.
95:588–591. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fukushige S and Horii A: Road to early
detection of pancreatic cancer: Attempts to utilize epigenetic
biomarkers. Cancer Lett. 342:231–237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ginestà MM, Mora J, Mayor R, Farré A,
Peinado MA, Busquets J, Serrano T, Capellá G and Fabregat J:
Genetic and epigenetic markers in the evaluation of pancreatic
masses. J Clin Pathol. 66:192–197. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Müller P, Jesnowski R, Liebe S, Rolfs A
and Löhr M: Simple method for DNA extraction from pancreatic juice
for PCR amplification assays. Int J Pancreatol. 25:39–43. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miller SA, Dykes DD and Polesky HF: A
simple salting out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res. 16:12151988. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Azuara D, Rodriguez-Moranta F, de Oca J,
Soriano-Izquierdo A, Mora J, Guardiola J, Biondo S, Blanco I,
Peinado MA, Moreno V, et al: Novel methylation panel for the early
detection of colorectal tumors in stool DNA. Clin Colorectal
Cancer. 9:168–176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Melki JR, Vincent PC and Clark SJ:
Concurrent DNA hypermethylation of multiple genes in acute myeloid
leukemia. Cancer Res. 59:3730–3740. 1999.PubMed/NCBI
|
|
20
|
Guo M, Jia Y, Yu Z, House MG, Esteller M,
Brock MV and Herman JG: Epigenetic changes associated with
neoplasms of the exocrine and endocrine pancreas. Discov Med.
17:67–73. 2014.PubMed/NCBI
|
|
21
|
Peng DF, Kanai Y, Sawada M, Ushijima S,
Hiraoka N, Kitazawa S and Hirohashi S: DNA methylation of multiple
tumor-related genes in association with overexpression of DNA
methyltransferase 1 (DNMT1) during multistage carcinogenesis of the
pancreas. Carcinogenesis. 27:1160–1168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Esteller M, Corn PG, Baylin SB and Herman
JG: A gene hypermethylation profile of human cancer. Cancer Res.
61:3225–3229. 2001.PubMed/NCBI
|
|
23
|
McKie AB, Filipe MI and Lemoine NR:
Abnormalities affecting the APC and MCC tumor suppressor gene loci
on chromosome 5q occur frequently in gastric cancer but not in
pancreatic cancer. Int J Cancer. 55:598–603. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
House MG, Guo M, Iacobuzio-Donahue C and
Herman JG: Molecular progression of promoter methylation in
intraductal papillary mucinous neoplasms (IPMN) of the pancreas.
Carcinogenesis. 24:193–198. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rodriguez J, Muñoz M, Vives L, Frangou CG,
Groudine M and Peinado MA: Bivalent domains enforce transcriptional
memory of DNA methylated genes in cancer cells. Proc Natl Acad Sci
USA. 105:19809–19814. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Matsubayashi H, Canto M, Sato N, Klein A,
Abe T, Yamashita K, Yeo CJ, Kalloo A, Hruban R and Goggins M: DNA
methylation alterations in the pancreatic juice of patients with
suspected pancreatic disease. Cancer Res. 66:1208–1217. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Azuara D, Rodriguez-Moranta F, de Oca J,
Sanjuan X, Guardiola J, Lobaton T, Wang A, Boadas J, Piqueras M,
Monfort D, et al: Novel methylation panel for the early detection
of neoplasia in high-risk ulcerative colitis and Crohn's colitis
patients. Inflamm Bowel Dis. 19:165–173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsubayashi H, Sato N, Fukushima N, Yeo
CJ, Walter KM, Brune K, Sahin F, Hruban RH and Goggins M:
Methylation of cyclin D2 is observed frequently in pancreatic
cancer but is also an age-related phenomenon in gastrointestinal
tissues. Clin Cancer Res. 9:1446–1452. 2003.PubMed/NCBI
|
|
29
|
Toyota M and Issa JP: CpG island
methylator phenotypes in aging and cancer. Semin Cancer Biol.
9:349–357. 1999. View Article : Google Scholar : PubMed/NCBI
|
